Market Expansion Genepharm's established international presence in over 90 countries creates significant sales opportunities for partners interested in expanding into European markets and leveraging its extensive distribution network.

Product Portfolio Specializing in both conventional and oncological solid formulations across multiple therapeutic areas, Genepharm offers a diverse product range suitable for pharmaceutical distributors and healthcare providers seeking high-quality generics.

Manufacturing Capacity With a robust production capacity of up to 500 million tablets annually and advanced production lines compliant with EU GMP standards, the company can support large-scale supply contracts for national or international pharma companies.

Acquisition Advantage Following its acquisition by MS Pharma Group, Genepharm is positioned for potential growth and increased market penetration, which can benefit sales partners aiming to leverage the backing of a rising global pharmaceutical entity.

Technological Infrastructure Genepharm’s investment in modern manufacturing technology and a strong digital presence indicates a commitment to quality and innovation, aligning with the needs of businesses focused on dependable supply chain and regulatory compliance.